3CQG
| Nucleoporin Nup107/Nup133 interaction complex, delta finger mutant | Descriptor: | Nuclear pore complex protein Nup107, Nuclear pore complex protein Nup133 | Authors: | Jeudy, S, Boehmer, T, Berke, I, Schwartz, T.U. | Deposit date: | 2008-04-02 | Release date: | 2008-07-01 | Last modified: | 2024-02-21 | Method: | X-RAY DIFFRACTION (3 Å) | Cite: | Structural and functional studies of Nup107/Nup133 interaction and its implications for the architecture of the nuclear pore complex. Mol.Cell, 30, 2008
|
|
3CQC
| Nucleoporin Nup107/Nup133 interaction complex | Descriptor: | Nuclear pore complex protein Nup107, Nuclear pore complex protein Nup133 | Authors: | Jeudy, S, Boehmer, T, Berke, I, Schwartz, T.U. | Deposit date: | 2008-04-02 | Release date: | 2008-07-01 | Last modified: | 2024-02-21 | Method: | X-RAY DIFFRACTION (2.53 Å) | Cite: | Structural and functional studies of Nup107/Nup133 interaction and its implications for the architecture of the nuclear pore complex. Mol.Cell, 30, 2008
|
|
1BNL
| ZINC DEPENDENT DIMERS OBSERVED IN CRYSTALS OF HUMAN ENDOSTATIN | Descriptor: | COLLAGEN XVIII, ZINC ION | Authors: | Ding, Y.-H, Javaherian, K, Lo, K.-M, Chopra, R, Boehm, T, Lanciotti, J, Harris, B.A, Li, Y, Shapiro, R, Hohenester, E, Timpl, R, Folkman, J, Wiley, D.C. | Deposit date: | 1998-07-30 | Release date: | 1998-10-14 | Last modified: | 2024-10-16 | Method: | X-RAY DIFFRACTION (2.9 Å) | Cite: | Zinc-dependent dimers observed in crystals of human endostatin. Proc.Natl.Acad.Sci.USA, 95, 1998
|
|
1XKS
| |
4PO4
| |
8EK5
| Engineered scFv 10LH bound to PHOX2B/HLA-A24:02 | Descriptor: | 10LH single chain fragment variable (scFv), Beta-2-microglobulin, GLYCEROL, ... | Authors: | Garfinkle, S.E, Florio, T.J, Sgourakis, N.G. | Deposit date: | 2022-09-20 | Release date: | 2023-12-06 | Last modified: | 2024-10-23 | Method: | X-RAY DIFFRACTION (2.11 Å) | Cite: | Structural principles of peptide-centric chimeric antigen receptor recognition guide therapeutic expansion. Sci Immunol, 8, 2023
|
|
1DY2
| Murine collagen alpha1(XV), endostatin domain | Descriptor: | COLLAGEN ALPHA1(XV) CHAIN, SULFATE ION | Authors: | Tisi, D, Hohenester, E, Sasaki, T, Timpl, R. | Deposit date: | 2000-01-21 | Release date: | 2001-01-21 | Last modified: | 2023-12-06 | Method: | X-RAY DIFFRACTION (2 Å) | Cite: | Endostatin Derived from Collagens Xv and Xviii Differ in Structural and Binding Properties, Tissue Distribution and Anti-Angiogenic Activity J.Mol.Biol., 301, 2000
|
|
1KOE
| ENDOSTATIN | Descriptor: | ENDOSTATIN | Authors: | Hohenester, E, Sasaki, T, Olsen, B.R, Timpl, R. | Deposit date: | 1998-01-22 | Release date: | 1999-02-16 | Last modified: | 2024-10-23 | Method: | X-RAY DIFFRACTION (1.5 Å) | Cite: | Crystal structure of the angiogenesis inhibitor endostatin at 1.5 A resolution. EMBO J., 17, 1998
|
|
8SBK
| Structure of HLA-A*24:02 in complex with peptide, LYLPVRVLI (ATG2A). | Descriptor: | 1,2-ETHANEDIOL, Beta-2-microglobulin, LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE, ... | Authors: | Mallik, L, Young, M.C, Sgourakis, N.G. | Deposit date: | 2023-04-03 | Release date: | 2023-12-06 | Last modified: | 2024-10-16 | Method: | X-RAY DIFFRACTION (1.8 Å) | Cite: | Structural principles of peptide-centric chimeric antigen receptor recognition guide therapeutic expansion. Sci Immunol, 8, 2023
|
|
8SBL
| Structure of HLA-A*24:02 in complex with peptide, LYLPVRVLI | Descriptor: | Beta-2-microglobulin, LEU-TYR-LEU-PRO-VAL-ARG-VAL-LEU-ILE, MHC class I antigen | Authors: | Mallik, L, Young, M.C, Sgourakis, N.G. | Deposit date: | 2023-04-03 | Release date: | 2023-12-06 | Last modified: | 2024-10-16 | Method: | X-RAY DIFFRACTION (3 Å) | Cite: | Structural principles of peptide-centric chimeric antigen receptor recognition guide therapeutic expansion. Sci Immunol, 8, 2023
|
|